Luis Palomero

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Small Cell Lung Cancer

Tyrosine Kinase

Top Venues

Cancer research

Clinical cancer research : an official journal of the American Association for Cancer Research

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Peter Lin, Corey Lourenco, Jennifer Cruickshank, Luis Palomero, Jenna E van Leeuwen, Amy H Y Tong, Katherine Chan, Samah El Ghamrasni, Miguel Angel Pujana, David W Cescon, Jason Moffat, Linda Z Penn
Topoisomerase 1 Inhibition in MYC-Driven Cancer Promotes Aberrant R-Loop Accumulation to Induce Synthetic Lethality. Cancer research (2023)
Qi Liu, Luis Palomero, Jade Moore, Ines Guix, Roderic Espin Garcia, Alvaro Aytés, Jian-Hua Mao, Amanda G Paulovich, Jeffrey R Whiteaker, Richard G Ivey, George Iliakis, Daxian Luo, Anthony J Chalmers, John Murnane, Miguel Angel Pujana, Mary Helen Barcellos-Hoff
Loss of TGFβ signaling increases alternative end-joining DNA repair that sensitizes to genotoxic therapies across cancer types. Science translational medicine 13 (580) (2021)
Adrià Bernat-Peguera, Juan Navarro-Ventura, Laura Lorenzo-Sanz, Victoria da Silva-Diz, Mattia Bosio, Luis Palomero, Rosa M Penin, Diana Pérez Sidelnikova, Josep Oriol Bermejo, Miren Taberna, Noelia Vilariño, Josep M Piulats, Ricard Mesia, Joan Maria Viñals, Eva González-Suárez, Salvador Capella, Alberto Villanueva, Francesc Viñals, Purificación Muñoz
FGFR Inhibition Overcomes Resistance to EGFR-targeted Therapy in Epithelial-like Cutaneous Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (5) (2020)